Abstract Advanced lipoxidation end-products (ALEs) and advanced glycoxidation end-products (AGEs) have a pathogenetic role in the development and progression of different oxidative based diseases including, diabetes, atherosclerosis and neurological disorders. AGEs and ALEs represent a quite complex class of compounds that are formed by different mechanisms, by heterogeneous precursors and that can be formed either exogenously or endogenously. There is a wide interest in AGEs and ALEs involving different aspects of research, among them: 1) set-up and application of analytical strategies to identify, characterize and quantify AGEs and ALEs in different pathophysiological conditions; 2) to elucidate the molecular basis of their biological effects; 3) to discover compounds able to inhibit AGEs/ALEs damaging effects not only as biological tools aimed at validating AGEs/ALEs as drug target, but also as promising drugs. All the above-mentioned research stages require a clear picture of the chemical formation of AGEs/ALEs but this is not simple, due to the complex and heterogeneous pathways, involving different precursors and mechanisms. In view of this intricate scenario, the aim of the present review is to group the main AGEs and ALEs and to describe, for each of them, the precursors and mechanisms of formation.

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation / G. Vistoli, D. Maddis De, A. Cipak, N. Zarkovic, M. Carini, G. Aldini. - In: FREE RADICAL RESEARCH. - ISSN 1071-5762. - 47:1(2013 Jun 17), pp. 3-27. [10.3109/10715762.2013.815348]

Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation

G. Vistoli
Primo
;
M. Carini
Penultimo
;
G. Aldini
Ultimo
2013

Abstract

Abstract Advanced lipoxidation end-products (ALEs) and advanced glycoxidation end-products (AGEs) have a pathogenetic role in the development and progression of different oxidative based diseases including, diabetes, atherosclerosis and neurological disorders. AGEs and ALEs represent a quite complex class of compounds that are formed by different mechanisms, by heterogeneous precursors and that can be formed either exogenously or endogenously. There is a wide interest in AGEs and ALEs involving different aspects of research, among them: 1) set-up and application of analytical strategies to identify, characterize and quantify AGEs and ALEs in different pathophysiological conditions; 2) to elucidate the molecular basis of their biological effects; 3) to discover compounds able to inhibit AGEs/ALEs damaging effects not only as biological tools aimed at validating AGEs/ALEs as drug target, but also as promising drugs. All the above-mentioned research stages require a clear picture of the chemical formation of AGEs/ALEs but this is not simple, due to the complex and heterogeneous pathways, involving different precursors and mechanisms. In view of this intricate scenario, the aim of the present review is to group the main AGEs and ALEs and to describe, for each of them, the precursors and mechanisms of formation.
Advanced glycation end products; Advanced lipoxidation end products; AGEs; ALEs; Protein carbonylation; Reactive carbonyls species
Settore CHIM/08 - Chimica Farmaceutica
17-giu-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
FREE RAD_RES_2013_AGES.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 787.41 kB
Formato Adobe PDF
787.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/222612
Citazioni
  • ???jsp.display-item.citation.pmc??? 252
  • Scopus 600
  • ???jsp.display-item.citation.isi??? 556
social impact